By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Praecis Pharmaceuticals Incorporated 

One Hampshire Street

Cambridge  Massachusetts  02139-1572  U.S.A.
Phone: 617-494-8400 Fax: 617-494-8414


SEARCH JOBS


Industry
Biotechnology


Collaborations

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient





Company News
GlaxoSmithKline (GSK) Successfully Completes Tender Offer For Shares Of Praecis Pharmaceuticals Incorporated (PRCS) 2/16/2007 10:06:30 AM
GlaxoSmithKline (GSK) Accepts Shares In Tender Offer For Shares Of Praecis Pharmaceuticals Incorporated (PRCS) And Commences Subsequent Offering Period 2/7/2007 12:26:50 PM
GlaxoSmithKline (GSK) Commences Tender Offer To Acquire Praecis Pharmaceuticals Incorporated (PRCS) 1/9/2007 11:14:23 AM
The Day In Review: Eli Lilly and Company (LLY) Stops Brain Cancer Trial 12/22/2006 5:11:25 PM
GlaxoSmithKline (GSK) To Acquire Praecis Pharmaceuticals Incorporated (PRCS) For $54.8M 12/21/2006 9:16:30 AM
Praecis Pharmaceuticals Incorporated (PRCS) Reports Third Quarter 2006 Financial Results 11/9/2006 11:43:49 AM
Praecis Pharmaceuticals Incorporated (PRCS) Presents Interim Clinical Data On PPI-2458 At The 18th EORTC-NCI-AACR Symposium 11/8/2006 11:45:40 AM
Praecis Pharmaceuticals Incorporated (PRCS) To Announce Third Quarter Financial Results On Thursday, November 9, 2006 11/1/2006 2:27:48 PM
Praecis Pharmaceuticals Incorporated (PRCS) Receives The Cerep Award For Research Related To Its Investigational Drug Candidate, PPI-2458 10/24/2006 11:43:58 AM
Praecis Pharmaceuticals Incorporated (PRCS) Presents Preclinical Data On PPI-2458 10/18/2006 11:13:31 AM
12345678
//-->